Exact Sciences Corporation (EXAS)
Mar 23, 2026 - EXAS was delisted (reason: acquired by ABT)
104.91
+0.99 (0.95%)
Inactive · Last trade price on Mar 20, 2026
Exact Sciences Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for Exact Sciences stock had an average target of $86.62, with a low estimate of $46 and a high estimate of $105.
Price Target: $86.62 (-17.43%)
Analyst Consensus: Hold
Price Target
Analyst Ratings
The average analyst rating for Exact Sciences stock from 17 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 17 | 3 | 3 | 2 | 1 | 0 |
| Buy | 3 | 0 | 1 | 1 | 1 | 1 |
| Hold | 2 | 18 | 18 | 19 | 20 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 21 | 22 | 22 | 22 | 7 |
Financial Forecast
Revenue This Year
3.66B
from 3.25B
Increased by 12.70%
Revenue Next Year
4.07B
from 3.66B
Increased by 11.25%
EPS This Year
0.63
from 0.07
Increased by 800.00%
EPS Next Year
2.07
from 0.63
Increased by 228.57%
EPS and Forward PE are based on non-GAAP adjusted numbers.